Amarin Corp. Plc (AMRN)
13.80
-0.24
(-1.71%)
USD |
NASDAQ |
Sep 11, 16:00
13.80
0.00 (0.00%)
After-Hours: 20:00
Amarin Market Cap : 289.83M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 289.83M |
| September 10, 2026 | 294.87M |
| September 09, 2026 | 302.22M |
| September 08, 2026 | 299.28M |
| September 04, 2026 | 286.26M |
| September 03, 2026 | 287.94M |
| September 02, 2026 | 287.73M |
| September 01, 2026 | 290.78M |
| August 31, 2026 | 291.51M |
| August 28, 2026 | 293.40M |
| August 27, 2026 | 295.50M |
| August 26, 2026 | 301.91M |
| August 25, 2026 | 297.18M |
| August 24, 2026 | 290.67M |
| August 21, 2026 | 295.92M |
| August 20, 2026 | 295.29M |
| August 19, 2026 | 302.01M |
| August 18, 2026 | 296.76M |
| August 17, 2026 | 294.24M |
| August 14, 2026 | 295.50M |
| August 13, 2026 | 297.18M |
| August 12, 2026 | 295.29M |
| August 11, 2026 | 294.24M |
| August 10, 2026 | 296.34M |
| August 07, 2026 | 301.59M |
| Date | Value |
|---|---|
| August 06, 2026 | 299.49M |
| August 05, 2026 | 302.64M |
| August 04, 2026 | 302.43M |
| August 03, 2026 | 296.97M |
| July 31, 2026 | 299.49M |
| July 30, 2026 | 298.86M |
| July 29, 2026 | 297.39M |
| July 28, 2026 | 292.98M |
| July 27, 2026 | 289.73M |
| July 24, 2026 | 284.27M |
| July 23, 2026 | 285.32M |
| July 22, 2026 | 287.63M |
| July 21, 2026 | 292.25M |
| July 20, 2026 | 285.32M |
| July 17, 2026 | 292.46M |
| July 16, 2026 | 297.49M |
| July 15, 2026 | 303.37M |
| July 14, 2026 | 301.48M |
| July 13, 2026 | 308.40M |
| July 10, 2026 | 312.18M |
| July 09, 2026 | 317.21M |
| July 08, 2026 | 318.26M |
| July 07, 2026 | 324.35M |
| July 06, 2026 | 330.01M |
| July 02, 2026 | 343.44M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Neurocrine Biosciences, Inc. | 15.87B |
| DBV Technologies SA | 701.32M |
| Alkermes Plc | 7.702B |
| Akari Therapeutics Plc | 19.78M |
| Liquidia Corp. | 5.947B |
Market Cap Related Metrics
| PS Ratio | 1.547 |
| Price to Book Value | 0.6533 |
| Price to Free Cash Flow | 18.49 |
| Price | 13.80 |
| Earnings Yield | -9.41% |